Skip to main content

Advertisement

SpringerLink
Log in

The efficacy of cevimeline hydrochloride in the treatment of xerostomia in Sjögren’s syndrome in southern Chinese patients: a randomised double-blind, placebo-controlled crossover study

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Cevimeline hydrochloride, a specific agonist of the M3 muscarinic receptor, is beneficial in the treatment of symptoms of xerostomia and xerophthalmia associated with Sjögren’s syndrome (SS). Cevimeline has not been evaluated in southern Chinese patients. Furthermore, the effects of cevimeline on health-related quality of life and oral health status are not known. In this randomised, double-blind, placebo-controlled crossover study, patients received cevimeline 30 mg or matched placebo three times per day over 10 weeks followed by a 4-week washout period before treatment crossover. Participants self-completed the following questionnaires: Xerostomia Inventory (XI), the General Oral Health Assessment Index (GOHAI), the Ocular Surface Disease Index (OSDI) and the Medical Outcomes Short Form (SF-36). Clinical assessments included sialometry, examination of the oral cavity for the degree of xerostomia and dental complications of xerostomia. Fifty patients (22 primary SS and 28 secondary SS) were enrolled in the trial. Forty-four patients completed the study. There was a significant improvement in the XI and GOHAI scores as well as the objective rating of xerostomic signs of the oral cavity after treatment with cevimeline. However, there was no improvement in salivary flow rates and dry eye symptoms. SS patients had lower SF-36 scores, but these did not improve after treatment with cevimeline.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mavragani CP, Moutsopoulos NM, Moutsopoulos HM (2006) The management of Sjögren’s syndrome. Nat Clin Pract Rheumatol 2:252–261

    Article  PubMed  CAS  Google Scholar 

  2. Fox RI, Stern M, Michelson P (2000) Update in Sjögren’s syndrome. Curr Opin Rheumatol 12:391–398

    Article  PubMed  CAS  Google Scholar 

  3. Anaya JM, Talal N (1999) Sjögren’s syndrome comes of age. Semin Arthritis Rheum 28:355–359

    Article  PubMed  CAS  Google Scholar 

  4. McMillan AS, Leung KCM, Leung WK, Wong MCM, Lau CS, Mok TMY (2004) Impact of Sjögren’s syndrome on oral health-related quality of life in southern Chinese. J Oral Rehabil 31:653–659

    Article  PubMed  CAS  Google Scholar 

  5. Vivino FB, Al-Hashimi I, Khan Z et al (1999) Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren’s syndrome: a randomized, placebo-controlled, fixed dose, multicenter trial. Arch Intern Med 159:174–181

    Article  PubMed  CAS  Google Scholar 

  6. Masunaga H, Ogawa H, Uematsu Y, Tomizuka T, Yasuda H, Takeshita Y (1997) Long-lasting salivation induced by a novel muscarinic receptor agonist SNI-2011 in rats and dogs. Eur J Pharmacol 339:1–9

    Article  PubMed  CAS  Google Scholar 

  7. Fife RS, Chase WF, Dore RK, Wiesenhutter CW, Lockhart PB, Tindall E, Suen JY (2002) Cevimeline for the treatment of xerostomia in patients with Sjögren syndrome: a randomized trial. Arch Intern Med 162:1293–1300

    Article  PubMed  CAS  Google Scholar 

  8. Petrone D, Condemi JJ, Fife R, Gluck O, Cohen S, Dalgin P (2002) A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren’s syndrome patients with xerostomia and keratoconjunctivitis sicca. Arthritis Rheum 46:748–754

    Article  PubMed  CAS  Google Scholar 

  9. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE et al (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American–European Consensus Group. Ann Rheum Dis 61:554–558

    Article  PubMed  CAS  Google Scholar 

  10. Leung KCM, McMillan AS, Leung WK, Wong MCM, Lau CS, Mok TMY (2004) Oral health condition and saliva flow in southern Chinese with Sjögren’s syndrome. Int Dent J 54:159–165

    PubMed  Google Scholar 

  11. Keech A, Simes J (1998) Design techniques to avoid bias. In: Introduction to clinical trials: clinical trials research methodology, statistical methods in clinical trials, the ICH GCP guidelines for the improvement of clinical research in Asia. Proceedings from the pre-conference courses of the Asian Clinical Trials Conference. The Clinical Trials Centre, Faculty of Medicine, the University of Hong Kong, pp 238–248

  12. Thomson WM, Chalmers JM, Spencer AJ, Williams SM (1999) The Xerostomia Inventory: a multi-item approach to measuring dry mouth. Community Dent Health 16:12–17

    PubMed  CAS  Google Scholar 

  13. McMillan AS, Tsang CSP, Wong MCM, Kam AY (2006) Efficacy of a novel lubricating system in the management of radiotherapy-related xerostomia. Oral Oncol 42:842–848

    Article  PubMed  Google Scholar 

  14. Wong MCM, Liu JK, Lo ECM (2002) Translation and validation of the Chinese version of GOHAI. J Public Health Dent 62:78–83

    Article  PubMed  Google Scholar 

  15. Walt JG, Rowe MM (1997) Evaluating the quality of life impact of dry eye: the Ocular Surface Disease Index [abstract]. Drug Inf J 31:1436

    Google Scholar 

  16. Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL (2000) Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol 118:615–621

    PubMed  CAS  Google Scholar 

  17. Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483

    Article  PubMed  Google Scholar 

  18. Lam CL, Gandek B, Ren XS, Chan MS (1998) Tests of scaling assumptions and construct validity of the Chinese (HK) version of the SF-36 Health Survey. J Clin Epidemiol 51:1139–1147

    Article  PubMed  CAS  Google Scholar 

  19. Lam CL, Tse EY, Gandek B, Fong DY (2005) The SF-36 summary scales were valid, reliable, and equivalent in a Chinese population. J Clin Epidemiol 58:815–822

    Article  PubMed  Google Scholar 

  20. Navazesh M, Christensen CM (1982) A comparison of whole mouth resting and stimulated salivary measurement procedures. J Dent Res 61:1158–1162

    PubMed  CAS  Google Scholar 

  21. Rhodus NL (1999) Sjögren’s syndrome. Quintessence Int 30:689–699

    PubMed  CAS  Google Scholar 

  22. WHO (1997) Oral health surveys. Basic methods 4th edn. Geneva

  23. Jansma J, Vissink A, Spijkervet FKL, Roodenburg JL, Panders AK, Vermey A et al (1992) Protocol for the prevention and treatment of oral sequelae resulting from head and neck radiation therapy. Cancer 70:2171–2180

    Article  PubMed  CAS  Google Scholar 

  24. Hamilton SE, Schlador ML, McKinnon LA, Chmelar RS, Nathanson NM (1998) Molecular mechanisms for the regulation of the expression and function of muscarinic acetylcholine receptors. J Physiol Paris 92:275–278

    Article  PubMed  CAS  Google Scholar 

  25. Mei L, Roeske WR, Izutsu KT, Yamamura HI (1990) Characterization of muscarinic acetylcholine receptors in human labial salivary glands. Eur J Pharmacol 176:367–370

    Article  PubMed  CAS  Google Scholar 

  26. Dai YS, Ambudkar IS, Horn VJ, Yeh CK, Kousvelari EE, Wall SJ et al (1991) Evidence that M3 muscarinic receptors in rat parotid gland couple to two second messenger systems. Am J Physiol 261:C1063–C1073

    PubMed  CAS  Google Scholar 

  27. Bacman S, Perez Leiros C, Sterin-Borda L, Hubscher O, Arana R, Borda E (1998) Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjögren’s syndrome. Invest Ophthalmol Vis Sci 39:151–156

    PubMed  CAS  Google Scholar 

  28. Ono M, Takamura E, Shinozaki K, Tsumura T, Hamano T, Yagi Y, Tsubota K (2004) Therapeutic effect of cevimeline on dry eye in patients with Sjögren’s syndrome: a randomized, double-blind clinical study. Am J Ophthalmol 138:6–17

    Article  PubMed  CAS  Google Scholar 

  29. Thomson WM, Williams SM (2000) Further testing of the xerostomia inventory. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 89:46–50

    Article  PubMed  CAS  Google Scholar 

  30. Locker D (2003) Dental status, xerostomia and the oral health-related quality of life of an elderly institutionalized population. Spec Care Dentist 23:86–93

    PubMed  Google Scholar 

  31. Department of Health (2002) Oral Health Survey 2001. Hong Kong Government of the Hong Kong Special Administrative Region

  32. Steele JG, Sanders AE, Slade GD, Allen PF, Lahti S, Nuttall N, Spencer AJ (2004) How do age and tooth loss affect oral health impacts and quality of life? A study comparing two national samples. Community Dent Oral Epidemiol 32:107–114

    Article  PubMed  Google Scholar 

  33. Suzuki K, Matsumoto M, Nakashima M, Takada K, Nakanishi T, Okada M, Ohsuzu F (2005) Effect of cevimeline on salivary components in patients with Sjögren syndrome. Pharmacology 74:100–105

    Article  PubMed  CAS  Google Scholar 

  34. Lam CLK, Lauder IJ, Lam TP, Gandek B (1999) Population based norming of the Chinese (HK) version of the SF-36 health survey. Hong Kong Practitioner 21:460–470

    Google Scholar 

  35. Thomas E, Hay E, Hajeer A, Silman A (1998) Sjögren’s syndrome: a community-based study of prevalence and impact. Br J Rheumatol 37:1069–1076

    Article  PubMed  CAS  Google Scholar 

  36. Kruize AA, Hené RJ, Kallenberg CG, van Bijsterveld OP, van der Heide A, Kater L, Bijlsma JW (1993) Hydroxychloroquine treatment for primary Sjögren’s syndrome: a two year double blind crossover trial. Ann Rheum Dis 52:360–364

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Oral Rehabilitation, Faculty of Dentistry, The University of Hong Kong, Hong Kong, China

    K. C. M. Leung & A. S. McMillan

  2. Periodontology, Faculty of Dentistry, The University of Hong Kong, Hong Kong, China

    M. C. M. Wong

  3. Dental Public Health, Faculty of Dentistry, The University of Hong Kong, Hong Kong, China

    W. K. Leung

  4. Division of Rheumatology, Faculty of Medicine, The University of Hong Kong, Hong Kong, China

    M. Y. Mok

  5. Division of Medicine & Therapeutics, University of Dundee, Ninewells Hospital & Medical School, Dundee, DD1 9SY, UK

    C. S. Lau

Authors
  1. K. C. M. Leung
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. S. McMillan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. C. M. Wong
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. W. K. Leung
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Y. Mok
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C. S. Lau
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. S. Lau.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leung, K.C.M., McMillan, A.S., Wong, M.C.M. et al. The efficacy of cevimeline hydrochloride in the treatment of xerostomia in Sjögren’s syndrome in southern Chinese patients: a randomised double-blind, placebo-controlled crossover study. Clin Rheumatol 27, 429–436 (2008). https://doi.org/10.1007/s10067-007-0723-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-007-0723-x

Keywords

Search

Navigation